Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism

BackgroundAstragaloside IV (AS-IV) is one of the most potent components of Astragalus. It has been reported to promote bone formation and inhibit osteoclastogenesis, suggesting its potential as a candidate for the prevention and treatment of postmenopausal osteoporosis (PMOP). The gut microbiota may...

Full description

Saved in:
Bibliographic Details
Main Authors: Huichao Wang, Zhongyue Huang, Guangnan Chen, Yang Li, Youwen Liu, Huijie Gu, Yujing Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1548491/full
Tags: Add Tag
No Tags, Be the first to tag this record!